Multivariate logistic analysis of predictors of response to immunosuppressive therapy in children with aplastic anemia: a double-center study

References

• Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006;108:2509–2519. doi: 10.1182/blood-2006-03-010777
   PubMed Web of Science ®Google Scholar
• Jeong DC, Chung NG, Kang HJ, et al. Epidemiology and clinical long-term outcome of childhood aplastic anemia in Korea for 15 years: retrospective study of the Korean Society of Pediatric Hematology Oncology (KSPHO). J Pediatr Hematol Oncol. 2011;33:172–178. doi: 10.1097/MPH.0b013e31820826a8
   PubMed Web of Science ®Google Scholar
• Marsh JC, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009;147:43–70. doi: 10.1111/j.1365-2141.2009.07842.x
   PubMed Web of Science ®Google Scholar
• Camitta BM, Rappeport JM, Parkman R, Nathan DG. Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood. 1975;45:355–363.
   PubMed Web of Science ®Google Scholar
• Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–1436. doi: 10.1182/blood-2016-08-693481
   PubMed Web of Science ®Google Scholar
• Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187–207. doi: 10.1111/bjh.13853
   PubMed Web of Science ®Google Scholar
• Barone A, Lucarelli A, Onofrillo D, et al. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Blood Cells Mol Dis. 2015;55:40–47. doi: 10.1016/j.bcmd.2015.03.007
   PubMed Web of Science ®Google Scholar
• Tichelli A, Schrezenmeier H, Socie G, et al. A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA working party of the European group for blood and marrow transplantation. Blood. 2011;117:4434–4441. doi: 10.1182/blood-2010-08-304071
   PubMed Web of Science ®Google Scholar
• Yoshida N, Kobayashi R, Yabe H, et al. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haematologica. 2014;99:1784–1791. doi: 10.3324/haematol.2014.109355
   PubMed Web of Science ®Google Scholar
• Nair V, Sondhi V, Sharma A, Das S, Sharma S. Survival after immunosuppressive therapy in children with aplastic anemia. Indian Pediatr. 2012;49:371–376. doi: 10.1007/s13312-012-0086-5
   PubMed Web of Science ®Google Scholar
• Bacigalupo A. Aplastic anemia: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2007;2007(1):23–28. doi: 10.1182/asheducation-2007.1.23
   Google Scholar
• Locasciulli A, Oneto R, Bacigalupo A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2007;92:11–18. doi: 10.3324/haematol.10075
   PubMed Web of Science ®Google Scholar
• Bacigalupo A, Oneto R, Schrezenmeier H, et al. First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: outcome of 955 patients treated 2001-2012. Am J Hematol. 2018;93:643–648. doi: 10.1002/ajh.25081
   PubMed Web of Science ®Google Scholar
• Chang MH, Kim KH, Kim HS, et al. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia. Eur J Haematol. 2010;84:154–159. doi: 10.1111/j.1600-0609.2009.01378.x
   PubMed Web of Science ®Google Scholar
• Scheinberg P, Wu CO, Nunez O, Young NS. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2009;144:206–216. doi: 10.1111/j.1365-2141.2008.07450.x
   PubMed Web of Science ®Google Scholar
• Boddu P, Garcia-Manero G, Ravandi F, et al. Clinical outcomes in adult patients with aplastic anemia: A single institution experience. Am J Hematol. 2017;92:1295–1302. doi: 10.1002/ajh.24897
   PubMed Web of Science ®Google Scholar
• Peffault DLR, Tabrizi R, Marcais A, et al. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia. Am J Hematol. 2018;93:635–642. doi: 10.1002/ajh.25050
   PubMed Web of Science ®Google Scholar
• Song MK, Chung JS, Joo YD, et al. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia? Eur J Haematol. 2009;83:72–78. doi: 10.1111/j.1600-0609.2009.01237.x
   PubMed Web of Science ®Google Scholar
• Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol. 2003;123:782–801. doi: 10.1046/j.1365-2141.2003.04721.x
   PubMed Web of Science ®Google Scholar
• Young NS, Bacigalupo A, Marsh JC. Aplastic anemia: pathophysiology and treatment. Biol Blood Marrow Transpl. 2010;16:S119–S125. doi: 10.1016/j.bbmt.2009.09.013
   PubMed Web of Science ®Google Scholar
• Kojima S, Hibi S, Kosaka Y, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. BLOOD. 2000;96:2049–2054.
   PubMed Web of Science ®Google Scholar
• Young NS, Scheinberg P, Calado RT. Aplastic anemia. Curr Opin Hematol. 2008;15:162-168. doi: 10.1097/MOH.0b013e3282fa7470
   PubMed Web of Science ®Google Scholar
• Marsh JC, Gupta V, Lim Z, et al. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. BLOOD. 2011;118:2351–2357. doi: 10.1182/blood-2010-12-327536
   PubMed Web of Science ®Google Scholar
• Marsh JC, Pearce RM, Koh MB, et al. Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation. Bone Marrow Transpl. 2014;49:42–48. doi: 10.1038/bmt.2013.115
   PubMed Web of Science ®Google Scholar
• Choi YB, Yi ES, Lee JW, et al. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor. Bone Marrow Transplant. 2017;52:47–52. doi: 10.1038/bmt.2016.223
   PubMed Web of Science ®Google Scholar
• Dufour C, Veys P, Carraro E, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric diseases Working Party and severe Aplastic Anaemia Working Party of EBMT. Br J Haematol. 2015;171:585–594. doi: 10.1111/bjh.13614
   PubMed Web of Science ®Google Scholar
• Xie X, Zhao H, Qin D, Qiao X. Pharmacokinetics and pharmacodynamics of two antithymocyte globulins in treatment of pediatric aplastic anemia. Int J Clin Exp Med. 2015;8:4349–4355.
   PubMed Web of Science ®Google Scholar
• Xie X, Shi W, Zhou X, Shao Y, Qiao X. Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-T lymphocyte globulin as a first-line treatment for children with aplastic anemia. Exp Hematol. 2014;42:431–438. doi: 10.1016/j.exphem.2014.02.003
   PubMed Web of Science ®Google Scholar
• Jalaeikhoo H, Khajeh-Mehrizi A. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study. Plos One. 2015;10:e126925. doi: 10.1371/journal.pone.0126925
   Web of Science ®Google Scholar
• Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4 + CD25highFOXP3+ regulatory T cells in vitro. Blood. 2008;111:3675–3683. doi: 10.1182/blood-2008-01-130146
   PubMed Web of Science ®Google Scholar
• Song EY, Kang HJ, Shin HY, et al. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients. Hum Immunol. 2010;71:88–92. doi: 10.1016/j.humimm.2009.10.002
   PubMed Web of Science ®Google Scholar